Haoma Revelation SupplementAvailability: 118 in stock
$75.00
Dream while awake – meet what your waking mind keeps out of reach
Ingredients: Espand (Syrian rue, Peganum harmala) seed extract, at the highest dose in our range.
Haoma is our Revelation dose: a precise, high dose of Espand-derived (Peganum harmala) beta-carbolines that puts the mind into a dream-like waking state – eyes closed, body still, awareness fully intact.
This is not a stimulant, and it is not a psychedelic in the ordinary sense. Beta-carbolines belong to a distinct class the research literature calls oneirogens – dream-generators. Where classic psychedelics amplify outward-facing, high-energy visual thinking, beta-carbolines do close to the opposite: they quiet active, effortful thinking and draw awareness inward, into the imagery and material the dreaming mind normally handles while you sleep.
Named for the sacred pressed drink of the Zoroastrian Magi – taken ritually to “experience death before dying” and return with knowledge.
“Homage to Haoma, that so elevates the mind of a poor man, that he gets enlightened through knowledge.” – passage from Zoroastrian Texts
Prepare properly. Set, setting, and dose all matter – the ancestors knew this, and the protocol on this page is built on it.
Availability: 118 in stock
The Ardā Wīrāz Nāmag records the fullest account of the Magi’s practice, and read closely it contains all three protocols of modern psychedelic-assisted therapy:
Set, setting, dose. The preparation instructions on this page are the direct descendant of that protocol.
Zoroastrian cosmology names Mēnōg — the invisible realm, reached not by travelling but by a shift in perception. The Persian philosopher Suhrawardi described Nâ-Kojâ-Abâd, “the country of nowhere,” transmitted to the West by Henri Corbin as the mundus imaginalis — a middle world, neither purely material nor purely abstract, perceived by trained imagination, and entered from the state between waking and sleeping.
Corbin insisted on imaginal, not imaginary — because imaginal perception is perception of something, not fabrication. Jung described a structurally identical territory and called it active imagination.
Whichever vocabulary you prefer — Mēnōg, the imaginal world, active imagination, the subconscious — these traditions are pointing at the same middle place. Haoma is the ancestral key to its door.
Beta-carbolines such as harmine [12] are unique neuromodulators that have been shown to exhibit anti-inflammatory activity in neurons [13] and promote neurogenesis by increasing levels of brain-derived neurotrophic factor (BDNF) [14] and human neural progenitor cells (hNPC) [15].
Beta-carbolines also interact with the sleep cycle via the pineal gland, the part of the brain that regulates the body’s circadian rhythm. The pineal gland regulates the sleep cycle via the synthesis of melatonin from serotonin (the “happiness hormone”) [16], and is also believed to be a site of endogenous neuromodulator synthesis via alternate pathways [17].
Not everything that alters consciousness does so the same way. The dream-research literature draws a distinction that matters here. Jonathan Ott defined an oneirogen as an agent that stimulates dreams or hypnagogic phenomena. Claude Rifat then split the category in two:
Haoma’s beta-carbolines belong to the second group. This is our central scientific claim, and it is what separates Haoma from every “psychedelic” product it might otherwise be confused with.
The term predates the modern vocabulary. Turner (1964) coined “oneirophrenic” — dream-mind — specifically for the harmala alkaloids, and Claudio Naranjo carried it into clinical work, describing the effect as eliciting vivid dream-like sequences with recurring archetypal content across sessions.
Naranjo also drew the contrast that best describes what Haoma actually feels like: tryptamine psychedelics (5-HT2A agonists) reinforce active, high-energy thinking and heightened outward emotion. Beta-carbolines do the reverse — they hinder active thinking, producing stillness, heaviness, and withdrawal from the external environment.
That is why the protocol is lie down, close your eyes, stop doing. Haoma is not asking you to engage the world; it is closing the outer door so the inner one can open.
Espand’s beta-carbolines (harmine, harmaline, tetrahydroharmine) are potent reversible inhibitors of monoamine oxidase-A (MAO-A) — the enzyme that clears serotonin, dopamine and noradrenaline. Sustained monoamine tone shifts the brain toward the neurochemistry of dreaming. Peganum harmala seed is extraordinarily rich in these alkaloids — up to roughly 10% w/w combined, several times the content of the Amazonian vine [18].
Dreaming is not idle. It is the mind’s own consolidation and emotional-processing system — which is why grief, unfinished feeling, and unresolved experience surface there first. Research into the therapeutic mechanisms of beta-carboline-containing preparations describes a consistent set of processes: somatic effects, introspection and emotional processing, increased self-connection, spiritual connection, and the gaining of insight and new perspective [19]. Haoma is built to open that channel on purpose, in a controlled setting, while you are awake enough to remember what you find.
All of Magi Ancestral Supplements’ products contain beta-carbolines or harmala compounds, but Haoma Revelation Supplement is our only product formulated with a high-dose quantity of Syrian rue-derived beta-carbolines, in an alkaloid ratio (harmine, harmaline, tetrahydroharmine, harmalol) meant to facilitate an altered state of perception for cognitive insight while awake.
Three neuroscience markers are commonly used to assess altered states of consciousness:

The chart above characterizes these markers and their translational subjective effect under four comparative conditions:
We formulated Haoma to provide a calmer and more controlled experience than a full psychedelic journey, but with noticeable psychological and physiological effects in pursuit of deep revelatory insight.


Haoma Revelation SupplementAvailability: 118 in stock